Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Ibecard Plus 150mg/12.5mg


Contraindicated
Foetotoxicity

Not recommended
Can inhibit the milk production
Ibecard Plus 150mg/12.5mg :
Type Medicine Non Marketed
Originator CoAprovel 150mg/12.5mg
Agent IPS
Distributor Bellapharma
Laboratory Benta Laboratories
Responsible Party Benta SAL
Origin Lebanon
Manufacturer Benta SAL
Manufacturing Type G
Origin Lebanon
ATC C09DA04

Your comment will appear shortly after approval

Ibecard Plus 150mg/12.5mg :

Revision Date : 28/06/2012


Effect Frequency
Agranulocytosis Not known
Anaphylactic reactions Not known
Angioedema (Angioneurotic oedema) (Quincke oedema) Not known
Angle closure glaucoma Not known
Aplastic anemia Not known
Arrhythmia Not known
Arthralgia (Pain joint) (Joint ache) Not known
Asthenia Not known
Blood cholesterol increased Not known
Blood creatine phosphokinase increased Common
Blood creatinine increased Common
Blood potassium decreased Uncommon
Blood sodium decreased Uncommon
Blood triglycerides increased Not known
Blood urea increased Common
Bone marrow failure Not known
Chest pain Uncommon
Constipation Not known
Cough Not known
Cutaneous lupus erythematosus Not known
Cutaneous vasculitis Not known
Decreased appetite Not known
Depression Not known
Diarrhoea (Diarrhea) Uncommon
Dizziness Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Not known
Dyspepsia Not known
Electrolyte imbalance Not known
Epigastric discomfort Not known
Fatigue Common
Flushing Uncommon
Glucosuria (Glycosuria) Not known
Haemolytic anemia Not known
Headache Not known
Hepatic function abnormal Not known
Hepatitis Not known
Hyperglycaemia Not known
Hyperkalaemia Not known
Hypersensitivity Not known
Hyperuricaemia Not known
Hypokalaemia (hypokalemia) Not known
Hyponatraemia (Hyponatremia) Not known
Hypotension Uncommon
Jaundice Uncommon
Jaundice cholestatic (Cholestatic icterus) Not known
Leucopenia (Leukopenia) Not known
Libido disorder Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Not known
Micturition disorder Common
Muscle spasms Not known
Myalgia Not known
Myopia Not known
Nausea Common
Necrotizing vasculitis Not known
Neutropenia Not known
Oedema Uncommon
Oedema peripheral Uncommon
Orthostatic dizziness Uncommon
Orthostatic hypotension Not known
Pancreatitis Not known
Paraesthesia (paresthesia) Not known
Photosensitivity reaction Not known
Pneumonitis Not known
Pulmonary oedema Not known
Pyrexia Not known
Renal failure Not known
Renal impairment Not known
Respiratory distress Not known
Restlessness Not known
Sexual dysfunction Uncommon
Sialadenitis Not known
Skin rash Not known
Sleep disorder (Sleep disturbance) Not known
Syncope Uncommon
Tachycardia Uncommon
Thrombocytopenia (Thrombopenia) Not known
Tinnitus Not known
Tubulointerstitial nephritis Not known
Urticaria Not known
Vasculitis Not known
Vertigo Not known
Vision blurred Not known
Vomiting Common
Xanthopsia Not known

Different Units By MoH Code

Revision Date : 01/09/2019

Ibecard Plus 150mg/12.5mg  MoH 8512 :
Form Tablet, Film-Coated
Packaging Blisters
Package Size Box of 30
Strength 150mg/12.5mg
Storage Condition <30°C protect from humidity & light
NSSF ✘
Quarantine ✘
Reg. Number 185801/13
Submission date 01/01/2013
Registration Year 2016
Archived Date 10/11/2025


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info